EVALUATION OF FRACTION OF EXHALED NITRIC OXIDE IN PATIENTS WITH STABLE ASTHMA - CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP

Văn Huy Phạm, Thị Phương Lan Đoàn

Main Article Content

Abstract

Objectives: To evaluate the results of measuring fraction of exhaled nitric oxide in patients with stable asthma - chronic obstructive pulmonary desease overlap receiving outpatient treatment at the Pulmonary disease management Clinic - Bach Mai Hospital. Methods: A cross-sectional descriptive study was carried out on 50 patients with a confirmed diagnosis of ACO according to Consensus GesEPOC-GEMA (Spanish COPD Asthma Management guidelines) who were treated as outpatients at the Pulmonary disease management Clinic - Bach Mai Hospital from September 2021 to September 2022. Results: Research on 50 ACO patients with a mean age of 66,5 ± 9,4 years old; all patients are male and 100% of the patients smoked. History of asthma (44%), allergic rhinitis (26%), 20% of patients have both asthma and allergic rhinitis; 10% with other allergies. The mean FeNO level is 20,88 ± 11,98 ppb. The FeNO levels in the group of patients with a history of asthma, a history of allergic rhinitis, and a history of ICS use were all greater than the group without a history, there was no statistically significant difference with p >0.05. There was no correlation between FeNO with age, cigarette smoking, mMRC dyspnea scale, Spirometry or the history of the exacerbation. The result shows that FeNO doesn’t have a correlation with the number of eosinophils. However, the FeNO levels with a history of asthma has a positive correlation with the number of eosinophils with correlation coefficient r =0,344, the difference was not statistically significant with p >0.05.  Conclusion: FeNO in ACO patients with a history of asthma and allergic rhinitis is higher than in patients without a history of asthma or allergic rhinitis. There was no correlation between FeNO and the number of eosinophils in peripheral blood, however the FeNO levels in ACO patients with a history of asthma has a positive correlation with the number of eosinophils in peripheral blood.

Article Details

References

1. Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis. PloS One. 2015;10(9):e0136065. doi:10.1371/journal.pone.0136065
2. Kobayashi S, Hanagama M, Ishida M, et al. Clinical Characteristics and Outcomes of Patients with Asthma-COPD Overlap in Japanese Patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:2923-2929. doi:10.2147/COPD.S276314
3. Gava G, Núñez A, Esquinas C, et al. Analysis of Blood Biomarkers in Patients with Chronic Obstructive Pulmonary Disease (COPD) and with Asthma-COPD Overlap (ACO). COPD. 2020;17(3): 306-310. doi:10.1080/ 15412555.2020.1761314
4. Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis. 2012;7:283-289. doi:10.2147/COPD.S30651
5. Nguyễn Như Vinh, Trần Văn Ngọc, Nguyễn Thị Thu Ba. Mức độ nitric oxide trong hơi thở ra ở bệnh nhân có bệnh hen và bệnh phổi tắc nghẽn mạn tính có chồng lấp (ACO) so với bệnh nhân bệnh phổi tắc nghẽn mạn tính đơn thuần và người bình thường. Tạp Chí Nghiên Cứu Học. 2018;2.
6. Chen FJ, Huang XY, Liu YL, Lin GP, Xie CM. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2385-2390. doi:10. 2147/COPD.S115378
7. Joo H, Han D, Lee JH, Rhee CK. Heterogeneity of asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2017;12:697-703. doi:10. 2147/COPD.S130943
8. Prieto L, Ruiz-Jimenez L, Marin J. The effect of spirometry on bronchial and alveolar nitric oxide in subjects with asthma. J Asthma Off J Assoc Care Asthma. 2013;50(6):623-628. doi:10. 3109/02770903.2013.790418
9. Tee AKH, Hui KP. Effect of spirometric maneuver, nasal clip, and submaximal inspiratory effort on measurement of exhaled nitric oxide levels in asthmatic patients. Chest. 2005; 127(1):131-134. doi:10.1378/chest.127.1.131
10. Takayama Y, Ohnishi H, Ogasawara F, Oyama K, Kubota T, Yokoyama A. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap. Int J Chron Obstruct Pulmon Dis. 2018;13:2525-2532. doi:10.2147/COPD.S167600